BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19054005)

  • 1. Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
    Fuller S; Liebens F; Carly B; Pastijn A; Rozenberg S
    Breast J; 2008; 14(6):603-4. PubMed ID: 19054005
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions.
    Hartmann LC; Degnim A; Schaid DJ
    J Clin Oncol; 2004 Mar; 22(6):981-3. PubMed ID: 14981099
    [No Abstract]   [Full Text] [Related]  

  • 3. Can genetic testing guide treatment in breast cancer?
    Tutt A; Ashworth A
    Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer.
    Hashemian AH; Hajizadeh E; Kazemnejad A; Atri M; Mehdipour P
    Saudi Med J; 2009 Jan; 30(1):41-4. PubMed ID: 19139771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations.
    Roukos DH
    N Engl J Med; 2007 Oct; 357(15):1555-6; author reply 1556. PubMed ID: 17933033
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and management of hereditary breast cancer.
    Narod SA; Offit K
    J Clin Oncol; 2005 Mar; 23(8):1656-63. PubMed ID: 15755973
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?
    Phillips KA; Lindeman GJ
    Future Oncol; 2014 Mar; 10(4):499-502. PubMed ID: 24754577
    [No Abstract]   [Full Text] [Related]  

  • 8. How reliable are BRCA1/2 mutation estimates?
    McClain MR; Palomaki GE; Haddow JE
    Cancer Res; 2007 May; 67(10):5057; author reply 5057-8. PubMed ID: 17510441
    [No Abstract]   [Full Text] [Related]  

  • 9. Surgical management of BRCA1 and BRCA2 carriers: bitter choices slightly sweetened.
    Rubinstein WS
    J Clin Oncol; 2005 Nov; 23(31):7772-4. PubMed ID: 16219930
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
    Biglia N; Mariani L; Ponzone R; Sismondi P
    Maturitas; 2008 Jun; 60(2):71-7. PubMed ID: 18472232
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic surgery in the complex decision-making management of BRCA mutation carriers.
    Briasoulis E; Ziogas D; Fatouros M
    Ann Surg Oncol; 2008 Jun; 15(6):1788-90; author reply 1791-2. PubMed ID: 18197455
    [No Abstract]   [Full Text] [Related]  

  • 12. Transmission of mutant alleles to female offspring of BRCA1 carriers in Poland.
    Gronwald J; Byrski T; Huzarski T; Narod SA; Lubinski J
    J Med Genet; 2005 Jul; 42(7):e40. PubMed ID: 15994865
    [No Abstract]   [Full Text] [Related]  

  • 13. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
    Matloff ET; Barnett RE; Bober SL
    Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
    James PA; Harris M; Lindeman GJ; Mitchell G
    J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisinger F; Huiart L
    J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
    [No Abstract]   [Full Text] [Related]  

  • 16. A lesser evil: prophylactic mastectomy for women at high risk for breast cancer.
    Schover LR
    J Clin Oncol; 2008 Aug; 26(24):3918-9. PubMed ID: 18711178
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral contraceptives and breast cancer risk.
    Ansink AC; Burger CW
    J Clin Oncol; 2007 Nov; 25(33):5327; author reply 5327-8. PubMed ID: 18024881
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

  • 20. Is early onset breast cancer with no family history a good criterion for testing BRCA1 and BRCA2 genes? A small population-based study.
    Beristain E; Martínez-Bouzas C; Mallabiabarrena G; Tejada MI
    Clin Genet; 2009 Jun; 75(6):576-8. PubMed ID: 19320659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.